000154458 001__ 154458
000154458 005__ 20240229123102.0
000154458 0247_ $$2doi$$a10.1007/s00103-020-03111-0
000154458 0247_ $$2pmid$$apmid:32157353
000154458 0247_ $$2ISSN$$a1436-9990
000154458 0247_ $$2ISSN$$a1437-1588
000154458 037__ $$aDKFZ-2020-00780
000154458 041__ $$ager
000154458 082__ $$a610
000154458 1001_ $$aAhrens, Wolfgang$$b0
000154458 245__ $$a[The investigation of health outcomes in the German National Cohort: the most relevant endpoints and their assessment].
000154458 260__ $$aHeidelberg$$bSpringer$$c2020
000154458 3367_ $$2DRIVER$$aarticle
000154458 3367_ $$2DataCite$$aOutput Types/Journal article
000154458 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1586860308_11878$$xReview Article
000154458 3367_ $$2BibTeX$$aARTICLE
000154458 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000154458 3367_ $$00$$2EndNote$$aJournal Article
000154458 520__ $$aThe focus of the German National Cohort, the largest population-based cohort study in Germany to date, is the investigation of the most important widespread diseases, such as cardiovascular diseases, diabetes, cancer, neurological and psychiatric disorders, and frequent respiratory and infectious diseases. This cohort will answer questions on the development of these diseases and on the impact of genetic, environmental and lifestyle-related risk factors. Another focus is on the identification of early, subclinical markers of emerging diseases. To answer these questions, a comprehensive assessment of these health outcomes as well as of all potential determinants and precursors is mandatory.This paper describes the various health outcomes that are assessed in the German National Cohort, as well as the examination modules that are applied for deep phenotyping of study participants. Repeated collection of biosamples as well as functional measurements and application of modern imaging techniques at various time points allow for assessing the dynamics of physiological changes related to the individuals' health status. The prognostic value of these changes for disease development will be explored and translated to novel approaches for prevention and personalised medicine. Incident diseases are being assessed through self-reports by study participants and through record linkage with data from health insurances and cancer registries. Additional information about clinical diagnoses is obtained from the treating physicians to ensure the highest possible validity.
000154458 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000154458 588__ $$aDataset connected to CrossRef, PubMed,
000154458 7001_ $$0P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b$$aGreiser, Karin H$$b1$$udkfz
000154458 7001_ $$aLinseisen, Jakob$$b2
000154458 7001_ $$aPischon, Tobias$$b3
000154458 7001_ $$aPigeot, Iris$$b4
000154458 773__ $$0PERI:(DE-600)1470303-8$$a10.1007/s00103-020-03111-0$$gVol. 63, no. 4, p. 376 - 384$$n4$$p376 - 384$$tBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz$$v63$$x1437-1588$$y2020
000154458 909CO $$ooai:inrepo02.dkfz.de:154458$$pVDB
000154458 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e0ac0d57cdb66d87f2d95ae5f6178c1b$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000154458 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000154458 9141_ $$y2020
000154458 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000154458 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000154458 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000154458 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBUNDESGESUNDHEITSBLA : 2017
000154458 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000154458 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000154458 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000154458 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000154458 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000154458 980__ $$ajournal
000154458 980__ $$aVDB
000154458 980__ $$aI:(DE-He78)C020-20160331
000154458 980__ $$aUNRESTRICTED